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Legionella pneumophila is a facultative intracellular pathogen capable of replicating within a broad range of hosts. One unique 
feature of this pathogen is the cohort of ca. 300 virulence factors (effectors) delivered into host cells via its Dot/Icm type IV 
secretion system. Study of these proteins has produced novel insights into the mechanisms of host function modulation by 
pathogens, the regulation of essential processes of eukaryotic cells and of immunosurveillance. In this review, we will briefly 
discuss the roles of some of these effectors in the creation of a niche permissive for bacterial replication in phagocytes and re-
cent advancements in the dissection of the innate immune detection mechanisms by challenging immune cells with L. pneu-
mophila. 
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Legionella AND THE DOT/ICM TYPE IV 
SECRETION SYSTEM 
The discovery of Legionella pneumophila dates back to 
1976, when a mysterious disease affected 221 American 
veterans attending the American Legion Convention in 
Philadelphia. The causative agent for this highly concerning 
outbreak was identified three year later and was designated 
as Legionella pneumophila, a gram-negative bacterium that 
belongs to the -proteobacteria (McDade et al., 1977). Sub-
sequent studies revealed that L. pneumophila is an intracel-
lular pathogen capable of replicating in highly diverse hosts, 
ranging from fresh water amoebae to mammalian alveolar 
macrophages (Stone et al., 1999). One salient feature asso-
ciated with L. pneumophila infection is that the bacterial 
phagosome does not undergo the default phagosomal matu-
ration process characterized by fusion with the lysosomal 
network, particularly in the early phase of infection; rather it 
develops into an organelle permissive for intracellular bac-
terial replication termed the Legionella-containing vacuole 
(LCV) (Ensminger and Isberg, 2009; Horwitz, 1983; Tilney 
et al., 2001) (Figure 1). The capability of this bacterium to 
construct such a unique niche is mostly attributed to the 
activity of effectors translocated by the Dot/Icm type IV 
secretion system (Huang et al., 2011; Isberg et al., 2009; 
Lifshitz et al., 2013; Luo and Isberg, 2004; Xu and Luo, 
2013; Zhu et al., 2011). These effectors function to 
re-orchestrate various host processes to allow intracellular 
bacterial growth. The infection biology of L. pneumophila 
provides an excellent example of the sophistication of the 
interactions between bacterial pathogens and their hosts. 
Further, investigations of the sensing of the Dot/Icm trans-
located proteins and/or their activity by immune cells such 
as macrophages has allowed the identification of novel im-
munosurveillance mechanisms often not seen in infections 
with more adapted pathogens. 
4 Zhu, W., et al.   Sci China Life Sci   January (2016) Vol.59 No.1 
 
Figure 1  Modulation of multiple host processes by Dot/Icm effectors. The formation of the LCV containing numerous L. pneumophila cells in permissive 
macrophages requires active modulation of multiple host processes by a large cohort of effectors. The events shown in this Figure include cell death, activa-
tion of the NF-B pathway, membrane transport between the ER and the Golgi apparatus, autophagy and the default phagosome maturation pathway that 
delivers newly formed phagosomes to the lysosomal network. Dot/Icm effectors involved in these processes were listed individually or as groups.  
MODULATION OF HOST PROCESSES BY 
DOT/ICM EFFECTORS 
L. pneumophila actively modulates host processes at both 
transcriptional and posttranslational levels. For example, 
infection with virulent L. pneumophila induces many an-
ti-apoptotic genes via the activation of the NF-B pathway 
(Abu-Zant et al., 2007; Losick and Isberg, 2006); effectors 
such as LegK1 and LnaB are involved in such activation 
(Ge et al., 2009; Losick et al., 2010). Histone methylation 
by RomA/LegAS4 causes the repression of innate immune 
genes and the activation of rDNA transcription, respectively 
(Li et al., 2013; Rolando et al., 2013), which are important 
to intracellular replication. Both the inhibition of protein 
synthesis (Belyi et al., 2006; Fontana et al., 2011) and the 
induction of cell death (via the activation of caspase 3) are 
mediated by multiple effectors (Zhu et al., 2013), most 
likely at the posttranslational level. Similar to many intra-
cellular pathogens, L. pneumophila also targets components 
of the host actin network (Franco et al., 2012; Guo et al., 
2014; Michard et al., 2015), likely to facilitate the biogene-
sis of the LCV by finely modulating the function of the ac-
tin cytoskeleton. 
The rapid conversion of the bacterial phagosome into an 
organelle resembling the endoplasmic reticulum (ER) is a 
unique feature associated with L. pneumophila infection; 
this process involves the function of many effectors, some 
of which target important signaling hubs of host membrane 
trafficking. Phosphatidylinositols (PIs) are essential in de-
fining organelle identity and in signaling cascades in vesicle 
trafficking and actin cytoskeleton structure (Di Paolo and De 
Camilli, 2006; Odorizzi et al., 2000). L. pneumophila har-
nesses the metabolism and cellular distribution of PIs using 
specific enzymes. On one hand, this bacterium injects a 
PI(3)P phosphatase into host cells (Toulabi et al., 2013), 
which may together with Rab5-activated VipD (Gaspar and 
Machner, 2014), function to remove PI(3)P from the surface 
of specific organelles (including the LCV), thus preventing 
the fusion of the LCV with the lysosomal network. On the 
other hand, L. pneumophila actively enriches PI(4)P on the 
LCV by employing enzymes of both bacterial and host ori-
gins. The PI-3-phosphatase SidF produces PI(4)P from 
PI(3,4)P2 directly or from PI(3,4,5)P3 together with OCRL, 
a host 5-phosphatase (Hsu et al., 2014). The host phospha-
tidylinositol-4-kinase IIIα (PI4KIIIα) also contributes to 
such enrichment (Hubber et al., 2014). The PI(4)P on the 
LCV allows the anchoring of PI(4)P-binding effectors such 
as SidM/DrrA, SidC and SdcA, which may compartmental-
ize the activity of these effectors to the surface of the LCV 
(Brombacher et al., 2009; Ragaz et al., 2008; Weber et al., 
2006). Enriched PI(4)P may also mimic the lipid composi-
tion of the cis-Golgi compartment (Di Paolo and De Camilli, 
2006; Odorizzi et al., 2000), making the LCV a “natural” 
recipient compartment for the incoming ER-derived vesicles. 
L. pneumophila also interferes with the biosynthesis of di-
acylglycerol (DAG) and phosphatidic acid (PA) in host cells 
(Viner et al., 2012) but the importance of such manipulation 
is not clear.  
Concomitant with its interference with host lipid metabo-
lism, L. pneumophila remodels the LCV membrane by hi-
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jacking the activity of key regulators of membrane traffick-
ing such as Arf1 (Nagai et al., 2002) and Rab1 (Machner 
and Isberg, 2006), the small GTPases essential for vesicle 
transport between the ER and the Golgi apparatus. At least 
five Dot/Icm effectors completely control the activity of this 
regulatory protein. Amongst these, SidM/DrrA is a multi-
functional protein; it anchors to the LCV surface by binding 
to PI(4)P and activates Rab1 with its guanine nucleotide 
exchange factor (GEF) activity (Machner and Isberg, 2006; 
Murata et al., 2006) and locks the GTPase in its active form 
with its AMPylating (adenylyl transferase) activity (Muller 
et al., 2010).  Following the removal of the AMPylation 
modification by SidD (Neunuebel et al., 2011; Tan and Luo, 
2011), Rab1 is inactivated by LepB, a bacterial GTPase 
activation protein (GAP) (Ingmundson et al., 2007). In mu-
rine macrophages, these proteins exert a temporal regulation 
of Rab1 activity on the LCV in the first 4 hours after bacte-
rial uptake (Neunuebel et al., 2011; Tan and Luo, 2011) 
(Figure 1). The complexity of Rab1 activity regulation is 
aggregated by the phosphorylcholine transferase AnkX 
(Mukherjee et al., 2011; Tan et al., 2011) and Lem3, an en-
zyme that reverses the modification imposed by AnkX (Tan 
et al., 2011). It is possible that AnkX targets Rab1 at the 
cis-Golgi compartment to block the fusion of ER-derived 
vesicles, which may facilitate the re-direction of such vesi-
cles to the LCV. In this model, the role of Lem3 is to safe-
guard (accidental) AnkX-mediated inhibition of Rab1 activ-
ity on the LCV. The bacterium also targets the Ran small 
GTPase to regulate microtubule polymerization, motility of 
its phagosome and infected cells (Rothmeier et al., 2013; 
Simon et al., 2014).  
Dot/Icm effectors also target other cellular events im-
portant for vesicle transport such as autophagy (Choy et al., 
2012) and the v-ATPase (Xu et al., 2010), which regulates 
membrane fusion by controlling the pH and other physio-
logical features of vacuoles. Finally, re-orchestration of the 
host ubiquitination pathways is emerging as an important 
branch of the bacterium’s strategy. At least eight Dot/Icm 
effectors appear to possess F-box or U-box domains typical 
of known E3 ligases (Hubber et al., 2013). Among these, 
LegU1, LegAU13/AnkB and LubX have been demonstrated 
to possess E3 ligase activity (Ensminger and Isberg, 2010; 
Kubori et al., 2008). SidC and SdcA are recently discovered 
unique E3 ligases important for efficient enrichment of both 
ubiquitinated species and proteins of ER origin onto the 
bacterial phagosome (Hsu et al., 2014). Interestingly, Rab1 
is monoubiquitinated during L. pneumophila infection in a 
manner that requires SidC/SdcA (Horenkamp et al., 2014), 
yet these two E3 ligases do not detectably ubiquitinate this 
small GTPase in vitro or in cells transfected to express these 
proteins (Hsu et al., 2014). Future identification of the pro-
tein substrates of these E3 ligases will provide exciting in-
sights into the signaling cascades that potentially link ubiq-
uitination to vesicle transport and other cellular events im-
portant for the biogenesis of the LCV.  
IMMUNE RECOGNITION IN 
L. pneumophila INFECTION 
Extracellular immune recognition  
Most individuals susceptible to L. pneumophila infection 
are immunocompromised (Kumpers et al., 2008), suggest-
ing that this bacterium does not effectively evade immune 
detection. The immune system recognizes L. pneumophila 
by employing an arsenal of germ-line coded Pat-
tern-Recognition-Receptor (PRRs) distributed on different 
cellular locales to perceive the presence of associated Path-
ogen-Associated-Molecular-Pattern (PAMPs), or by detect-
ing alterations of the cellular activities imposed by the bac-
terium (Abt et al., 2012) 
The PRRs are categorized based on the subcellular loca-
tion where the receptor initiates the signaling. 
Toll-like-receptors (TLRs) and C-type lectins are among the 
most well-characterized membrane associated receptors that 
mainly function to recognize extracellular ligands (some 
TLRs are located in endosomes that recognize intracellular 
ligands) (Lee and Kim, 2007). These receptors recognize a 
wide range of ligands. For example, mouse codes for 13 
TLRs, and the ligands to these receptors includes bacterial 
lipopolysaccharides (LPS), peptidoglycans, triacyl lipopep-
tides, and flagellin, as well as the zymosan of fungi (Broz 
and Monack, 2013). It has been demonstrated that TLRs are 
essential to mounting appropriate immune responses to L. 
pneumophila, as mice lacking MyD88, the signaling adaptor 
shared by all TLRs except TLR3, fail to clear L. pneumoph-
ila in the lung and eventually succumb to acute pulmonary 
infection, with bacteria spreading to lymph nodes and the 
spleen (Archer and Roy, 2006). Among TLRs, TLR2, TLR4 
and TLR5 are the major contributors to the recognition of L. 
pneumophila during infection, as the lack of TLR2 enhanc-
es bacterial growth in a mouse model, and the polymor-
phisms of TLR4 and TLR5 are associated with resistance to 
Legionnaires’ disease (Archer et al., 2009; Hawn et al., 
2005; Hawn et al., 2003).  
Intracellular immune recognition  
Extracellular PRRs alone are not sufficient in defending 
against microbial infections, especially those by intracellu-
lar pathogens. It is therefore not surprising that mammals 
code for a large cohort of cytoplasmic PRRs, including the 
NOD-like receptors (NLRs), pyrin and HIN domain con-
taining family (PYHIN), RIG-I-like receptors (RLRs) and 
numerous cytosolic nucleic acid sensors to guard the cytosol 
from invading microbes (Broz and Monack, 2013). Some 
NLRs upregulate the transcription of downstream signaling 
components, such as the NF-B and the IFN-β production 
pathways upon engaging their ligands (Strober et al., 2006). 
Other NLRs, however, drive the assembly of large protein 
complexes termed inflammasomes, which cause pyroptotic 
cell death and the secretion of mature inflammatory cyto-
kines, such as IL-1β and IL-1α (Lamkanfi and Dixit, 2014). 
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The diverse ligand recognition capacity of NLRs makes 
them one of the most important guardians of the cytoplasm. 
For example, NLRP1b responds to the protease activity of 
the Bacillus anthracis lethal toxin and to Toxoplasma gondii 
infection (Cirelli et al., 2014), whereas the AIM2 inflam-
masome responds to cytosolic DNA molecules (Rathinam et 
al., 2010). Similarly, the NLRC4 inflammasome responds to 
many bacterial PAMPs, such as the rod and needle proteins 
of bacterial Type III secretion system as well as flagellin 
(Zhao et al., 2011). The capability of NLRC4 to recognize 
such a wide repertoire of PAMPs is attributed to the NAIP 
proteins (also called baculoviral IAP repeat-containing pro-
tein), which serve as adaptors to bridge the interaction be-
tween NLRC4 and the PAMP molecules (Zhao et al., 2011). 
So far, the NLRP3 inflammasome is known to respond to 
the most diverse PAMPs, which include bacterial, fungal 
and viral pathogens, as well as pore formation toxins, pro-
tein amyloid, extracellular ATP, and inorganic substances 
such as silica and alum (Lamkanfi and Dixit, 2014).  
The discovery of the intracellular sensor for flagellin is 
largely attributed to the research aiming at understanding 
the inability of macrophages from most of the inbred mouse 
strains to support intracellular L. pneumophila replication 
(Yamamoto et al., 1988). For example, BMDMs (Bone 
Marrow Derived Macrophage) from C57BL/6 mouse effec-
tively clear L. pneumophila, and the bacterial clearance is 
accompanied by extensive pyroptosis (Derre and Isberg, 
2004), suggesting the involvement of active host immune 
responses. However, L. pneumophila successfully replicates 
in macrophages from A/J mice (Yamamoto et al., 1988). 
Taking advantage of the sharply different responses of the 
two mouse strains to L. pneumophila, Dietrich et al. mapped 
the genetic elements responsible for the permissiveness of 
A/J mice to the Lgn1 locus, which was later pinpointed to 
the gene Naip5 (Diez et al., 2003). The very same pheno-
type also was utilized to identify flagellin as the bacterial 
factor that engages Naip5 (Molofsky et al., 2006; Ren et al., 
2006). Upon engaging flagellin, Naip5 recruits and activates 
NLRC4, which recruits and activate caspase-1(Kofoed and 
Vance, 2011; Zhao et al., 2011), leading to the secretion of 
inflammatory cytokines (IL-18 and IL-1β) and pyroptotic 
cell death. These events eventually lead to further recruit-
ment of other immune cells and the removal of the replica-
tive niche, explaining the resistance to L. pneumophila in-
fection by most mouse lines.  
In permissive mouse macrophages, L. pneumophila 
maintains its lifestyle as a vacuolar pathogen. The stability 
of LCV membrane is affected by the lipase PlaA, which 
seems to destabilize the vacuole (Creasey and Isberg, 2012). 
Interestingly, the effects of PlaA are counteracted by the 
effector SdhA, which maintains the integrity of the LCV, 
very likely by modulating host membrane trafficking 
(Creasey and Isberg, 2012). L. pneumophila lacking SdhA 
aberrantly enters the cytosol, leading to the activation of the 
AIM-2 inflammasome and the noncanonical caspase-11 
inflammasome (Aachoui et al., 2013; Ge et al., 2012). These 
phenomena have facilitated the discovery of the caspase-11 
inflammasome, which was later shown to be activated di-
rectly by intracellular LPS (Aachoui et al., 2013; Shi et al., 
2014). These exciting successes in revealing previously 
underappreciated immune pathways by studying L. pneu-
mophila infection clearly demonstrate the great potential of 
investigating host responses using less adapted pathogens 
(Figure 2). 
Other cytoplasmic PRRs such as RLRs, including retin-
oic acid-inducible gene I (RIG-I), LGP2 and the melanoma 
differentiation-associated protein 5 (MDA5), detect nucleic 
acid and their derivatives, which are one of most important 
categories of MAMPs (Broz and Monack, 2013). RIG-I, for 
example, recognizes cytoplasmic dsRNA to promote the 
prion conversion of MAVS (Mitochondrial antiviral-   
signaling protein), which signals to activate the production 
of IFN-β (Cai et al., 2014). Of particular interest is the 
long-anticipated revelation of the major cytoplasmic dsD-
NA sensor, cGAS (Cyclic GMP-AMP synthase) (Sun et al., 
2013). This sensor is special as it is an enzyme itself, which 
catalyzes the formation of cyclic di-GMP-AMP upon rec-
ognizing dsDNA. The cyclic di-GMP-AMP is then sensed 
by STING (STimulator of INterferon Genes), which signals 
the production of type I IFN (Burdette et al., 2011). L. 
pneumophila can also be recognized by the AIM2 inflam-
masome, probably by bacterial DNA “leaked” into the host 
cytosol by the Dot/Icm system (Berrington et al., 2010) 
(Figure 2). Since L. pneumophila infection also induces 
Type I Interferon production in a STING-(stimulator of in-
terferon genes) dependent manner, it is tempting to postu-
late that the “leaked” bacterial DNA also engages the cGAS 
(cyclic GMP-AMP synthase)-c-di-AMP-GMP-STING 
pathway (Ge et al., 2012; Lippmann et al., 2011; Monroe et 
al., 2009) (Figure 2). Alternatively, bacterial cyclic 
di-GMP-AMP may reach host cytosol via the Dot/Icm sys-
tem or in conjunction with other transporters, akin to that 
observed in Listeria monocytogenes (Crimmins et al., 2008; 
Woodward et al., 2010).  
In addition to pyroptosis, intracellular surveillance of 
foreign molecules causes permeabilization of the lysosome, 
an organelle that is emerging as a central signaling hub for 
various pathological stresses, including stroke, acute pan-
creatitis, parasitic and infections (Aits and Jaattela, 2013). 
Upon perceiving these stresses, lysosomal membranes un-
dergoes selective or complete permeabilization, leading to 
the release into the cytosol, of its contents, including prote-
ases of the cathepsin family (Aits and Jaattela, 2013). Ca-
thepsins are capable of inducing cell death of various forms 
(Turk and Turk, 2009). A recent discovery reveals that L. 
pneumophila “accidently” delivers RpsL, a conserved bac-
terial ribosomal protein into the cytosol, where it causes 
lysosomal membrane permeabilization (LMP), presumably 
by activating a signaling cascade upon engaging a yet to be 
identified receptor (Zhu et al., 2015). Cathepsins such ca- 
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Figure 2  Immune recognition of L. pneumophila. Interactions between L. pneumophila and macrophages activate immune responses at both transcriptional 
and posttranslational levels. The most notable events are those that occur in response to the activity of the Dot/Icm transporter, including the production of 
type I interferon, the activation of various inflammasomes and the induction of lysosomal membrane permeabilization (LMP). AIM2, Absent in melanoma 2; 
Casp-1, capase-1; Casp-11, caspase-11; cGAS, cyclic di-GMP-AMP synthase; IFN, Interferon; IRF-3, Interferon regulatory factor 3; LPS, lipopolysaccha-
ride; MAVS, mitochondrial antiviral-signaling protein; MyD88, Myeloid differentiation primary response gene 88; Naip5, NLR family, apoptosis inhibitory 
protein 5; NF-B, nuclear factor kappa-light-chain-enhancer of activated B cells; NLRC4, NLR family CARD domain-containing protein 4; NOD1/2, Nu-
cleotide-binding oligomerization domain-containing protein 1 and 2; RIG-I, retinoic acid-inducible gene 1; STING, stimulator of interferon genes; TLR2, 
Toll like receptor 2; TLR5, Toll like receptor 5.  
thepsin B and cathepsin D are released in response to infec-
tions with L. pneumophila expressing wild type RpsL or 
artificially delivered protein (Zhu et al., 2015). More inter-
estingly, a Lys88Arg mutation that also confers resistance 
to the antibiotic streptomycin, allows the bacterium to rep-
licate in mouse macrophage (Zhu et al., 2015), suggesting 
the recognition of the same epitope by antibiotics and the 
immune system.  
IMMUNITY TRIGGERED BY 
L. pneumophila EFFECTORS 
PAMPs are not the only microbe-associated features sensed 
by that the immune systems are sensing. The observation 
that different cultivars of the same plant respond distinc-
tively to different pathogen races has prompted plant 
pathologists to postulate the “gene-for-gene” hypothesis 
(Flor, 1971), which suggests that resistant plants code for 
the “resistant gene (R gene)” that is required for the recog-
nition of the virulence factor “avirulence gene (avr gene)”. 
Since the presence of the avr gene is sufficient to trigger 
immune responses from resistant plants, it was proposed 
that the R gene product directly recognizes the gene product 
of the Avr, which is similar to the PRR-PAMP paradigm in 
metazoans (Stuart et al., 2013). However, as the interactions 
between Avr and R genes were rarely demonstrated, and 
that the Avr genes usually codes for bacterial virulence fac-
tors with distinct biochemical activities, Dangl and other 
researchers hypothesized that R gene products are not rec-
ognizing the Avr proteins per se, but instead their biochem-
ical consequences (Chisholm et al., 2006). This hypothesis 
was supported by the observation that Avr proteins lacking 
their enzymatic activities are not immunogenic (Jones and 
Dangl, 2006). Thus, the immunity triggered by perceiving 
the biochemical consequences of bacterial effectors is de-
fined as effector-triggered immunity (ETI) (Jones and 
Dangl, 2006). Similar hypothesis called “pattern of patho-
genesis” was proposed for the mammalian system (Jones 
and Dangl, 2006). It is now clear that ETI exists in metazo-
an (Chisholm et al., 2006) as well. For instance, modifica-
tion of the host protein RAC2 by the Escherichia coli CNF 
(cytotoxic necrotizing factor-1) activates the NF-B path-
way (Boyer et al., 2011; Gurcel et al., 2006). Similarly, the 
pore formation activity of various bacterial toxins activates 
the NLRP3 inflammasome (Boyer et al., 2011; Gurcel et al., 
2006) and the GAP activity of the Yersinia T3SS effector 
YopE triggers bacterial killing by macrophages (Wang et 
al., 2014). Finally, a recent study reveals that the Pyrin in-
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flammasome is an R gene equivalent in mammals, which 
senses various effector-mediated modifications on the small 
GTPase RhoA, including AMPylation, ADP-ribosylation, 
deamindation and glucosylation (Xu et al., 2014). Thus, ETI 
is an important branch of innate immune surveillance in 
metazoans.  
ETI also contributes to the immune response to L. pneu-
mophila infection. In macrophages, the MAP kinase path-
way and the NF-B pathway are highly induced by infec-
tions by wild type L. pneumophila but not by its dot/icm 
mutants (Abu-Zant et al., 2007; Losick and Isberg, 2006; 
Shin et al., 2008). Interestingly, protein synthesis inhibition 
conferred by at least five Dot/Icm substrates is part of the 
signals sensed by both the NF-B and the MAP kinase 
pathways (Fontana et al., 2011; Fontana et al., 2012). 
Pro-longed activation of the NF-B pathway seen in infec-
tions with wild type L. pneumophila is achieved by delayed 
re-synthesis of IB, the labile inhibitory protein of NF-B 
(Fontana et al., 2011). The activation of the MAP kinase 
response by protein synthesis inhibition is multifaceted. 
First, many genes involved in this pathway are transcribed 
but not translated. The “frustrated” responses trigger sig-
naling pathways to allow selective translation of at least two 
inflammatory cytokines, IL-1α and IL-1β, in a MyD88 de-
pendent manner (Asrat et al., 2014). Analyses in a pulmo-
nary infection mouse model suggest that, in vivo, bypassing 
the translational inhibition is mediated by the bystander 
cells not infected by L. pneumophila (Copenhaver et al., 
2015).  
In sum, the study of L. pneumophila pathogenesis in the 
past decade has greatly advanced our understanding of not 
only the mechanisms underlying the interactions between 
this pathogen and its hosts, but also the mechanisms in the 
biochemistry of posttranslational modifications, signaling 
and immune detection. Given the fact that the activity has 
only been assigned to a small fraction of the Dot/Icm sub-
strates, it is anticipated that more excitement will be made 
in our analysis of the hundreds of effectors and the host 
response to these proteins in years to come.  
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